897 related articles for article (PubMed ID: 10534339)
1. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Hicklin DJ; Huber J; Nakatani T; Tsujinoue H; Yanase K; Imazu H; Fukui H
Hepatology; 2002 Apr; 35(4):834-42. PubMed ID: 11915029
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis.
Yoshiji H; Kuriyama S; Ways DK; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Tsujinoue H; Nakatani T; Shibuya M; Fukui H
Cancer Res; 1999 Sep; 59(17):4413-8. PubMed ID: 10485491
[TBL] [Abstract][Full Text] [Related]
4. The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model.
Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Fukui H
Hepatology; 2001 Apr; 33(4):841-7. PubMed ID: 11283848
[TBL] [Abstract][Full Text] [Related]
5. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells.
Yoshiji H; Kuriyama S; Yoshii J; Yamazaki M; Kikukawa M; Tsujinoue H; Nakatani T; Fukui H
Hepatology; 1998 Dec; 28(6):1489-96. PubMed ID: 9828211
[TBL] [Abstract][Full Text] [Related]
7. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.
Belletti B; Ferraro P; Arra C; Baldassarre G; Bruni P; Staibano S; De Rosa G; Salvatore G; Fusco A; Persico MG; Viglietto G
Oncogene; 1999 Aug; 18(34):4860-9. PubMed ID: 10490819
[TBL] [Abstract][Full Text] [Related]
8. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma.
Ng IO; Poon RT; Lee JM; Fan ST; Ng M; Tso WK
Am J Clin Pathol; 2001 Dec; 116(6):838-45. PubMed ID: 11764072
[TBL] [Abstract][Full Text] [Related]
9. The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
Giatromanolaki A; Sivridis E; Athanassou N; Zois E; Thorpe PE; Brekken RA; Gatter KC; Harris AL; Koukourakis IM; Koukourakis MI
J Pathol; 2001 May; 194(1):101-8. PubMed ID: 11329148
[TBL] [Abstract][Full Text] [Related]
10. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
11. Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells.
Yoshiji H; Yoshii J; Ikenaka Y; Noguchi R; Yanase K; Tsujinoue H; Imazu H; Fukui H
Int J Oncol; 2002 Jun; 20(6):1227-31. PubMed ID: 12012003
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
Brekken RA; Overholser JP; Stastny VA; Waltenberger J; Minna JD; Thorpe PE
Cancer Res; 2000 Sep; 60(18):5117-24. PubMed ID: 11016638
[TBL] [Abstract][Full Text] [Related]
13. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.
Millauer B; Shawver LK; Plate KH; Risau W; Ullrich A
Nature; 1994 Feb; 367(6463):576-9. PubMed ID: 8107827
[TBL] [Abstract][Full Text] [Related]
15. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.
Millauer B; Longhi MP; Plate KH; Shawver LK; Risau W; Ullrich A; Strawn LM
Cancer Res; 1996 Apr; 56(7):1615-20. PubMed ID: 8603410
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the vascular endothelial growth factor receptor-1 in murine hepatocellular carcinoma development.
Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Yanase K; Namisaki T; Kitade M; Yamazaki M; Tsujinoue H; Masaki T; Fukui H
J Hepatol; 2004 Jul; 41(1):97-103. PubMed ID: 15246214
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system.
Kremer C; Breier G; Risau W; Plate KH
Cancer Res; 1997 Sep; 57(17):3852-9. PubMed ID: 9288799
[TBL] [Abstract][Full Text] [Related]
18. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.
Breier G; Clauss M; Risau W
Dev Dyn; 1995 Nov; 204(3):228-39. PubMed ID: 8573716
[TBL] [Abstract][Full Text] [Related]
19. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
[TBL] [Abstract][Full Text] [Related]
20. Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype.
Ortéga N; Jonca F; Vincent S; Favard C; Ruchoux MM; Plouët J
Am J Pathol; 1997 Nov; 151(5):1215-24. PubMed ID: 9358746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]